Skip to main content
All lobbying filings

GUTTMACHER INSTITUTE

Lobbying for GUTTMACHER INSTITUTE

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$9,749
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 4
  • SAMIRA DAMAVANDI
    Previously held: Senior Federal Policy Associate
  • ANNA BERNSTEIN
    Previously held: Principal Federal Policy Advisor
  • AMY FRIEDRICH-KARNIK
    Previously held: Director of Federal Policy
  • ANN NOLI VEGA
    Previously held: Senior Digital Communications Manager

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

FY 27 Appropriations- Emailed Senate offices to sign on to FY 27 international family planning/reproductive health - Signed on to a FY 27 appropriations letter urging the House to support reproductive health and rights priorities - Signed on to a FY 27 appropriations letter to the House supporting funding for domestic family planning programs

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

-Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff from Rep. Schakowsky's offices to discuss reintroduction of bill -H.R 8582/ S. 4426- Protecting Human Rights and Public Health in Foreign Assistance Act- Endorsed bill, emailed staff to cosponsor bill, social media content and development, met with colleagues to discuss advocacy strategies

- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - S.4701 Freedom to Travel for Health Care Act of 2026- social media content development

 Bills named in this filing 11
  • H.R. 4611
    EACH Act of 2025
  • H. Res. 1389
    Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponi…
  • S. Res. 732
    A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed…
  • H. Res. 1285
    Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-rev…
  • S. 4701
    Freedom to Travel for Health Care Act of 2026
  • H.R. 9470
    SAFER Health Act of 2026
  • S. 4922
    Reproductive Health Travel Fund Act of 2026
  • H.R. 9441
    SAFE Training for OB-GYNs Act
  • H.R. 999
    Right to Contraception Act
  • H.R. 8582
    Protecting Human Rights and Public Health in Foreign Assistance Act
  • S. 4426
    STOP Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem